Fang-Shu Ou Selected Research

Fang-Shu Ou Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2018
24	Colorectal Neoplasms (Colorectal Cancer) 12/2024 - 01/2019
13	Colonic Neoplasms (Colon Cancer) 12/2024 - 01/2018
10	ST Elevation Myocardial Infarction 07/2011 - 02/2008
10	Hemorrhage 05/2011 - 02/2008
8	Acute Coronary Syndrome 12/2010 - 02/2008
6	Leukemia 03/2024 - 10/2019
6	Disease Progression 01/2022 - 07/2017
5	Adenocarcinoma 01/2021 - 07/2017
5	Myocardial Infarction 05/2011 - 01/2009
4	Non-ST Elevated Myocardial Infarction 05/2011 - 09/2008
3	Stroke (Strokes) 05/2011 - 02/2008
3	Cardiogenic Shock 05/2011 - 01/2009
3	Heart Failure 05/2011 - 05/2009
2	Residual Neoplasm 12/2024 - 12/2020
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 12/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2019
2	Microsatellite Instability 10/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 03/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2011 - 04/2010
2	Chronic Renal Insufficiency 03/2009 - 03/2009
2	Unstable Angina 09/2008 - 02/2008
1	Hypoxia (Hypoxemia) 02/2024
1	Inflammation (Inflammations) 01/2024
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Fatigue 10/2021
1	Prostatic Neoplasms (Prostate Cancer) 08/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Pathologic Complete Response 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Genetic Risk Score 07/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2018

Drug/Important Bio-Agent (IBA)

10	Cetuximab (Erbitux)FDA Link 03/2024 - 01/2019
9	Bevacizumab (Avastin)FDA Link 03/2024 - 10/2019
7	Biomarkers (Surrogate Marker)IBA 12/2024 - 01/2018
6	DNA (Deoxyribonucleic Acid)IBA 12/2024 - 12/2018
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 07/2017
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 07/2017
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2017
3	Clopidogrel (Plavix)FDA Link 11/2008 - 02/2008
2	LigandsIBA 01/2024 - 01/2022
2	Dietary Fats (Dietary Fat)IBA 01/2023 - 10/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2022
2	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2021
2	Docetaxel (Taxotere)FDA Link 08/2021 - 01/2021
2	Insulin (Novolin)FDA Link 01/2020 - 01/2011
2	Vitamin D FDA LinkGeneric 12/2019 - 07/2019
2	hydroxide ionIBA 12/2019 - 07/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 10/2018
2	ORALIT (ORS)IBA 11/2010 - 05/2009
2	TroponinIBA 11/2010 - 09/2009
1	Calcibiotic Root Canal SealerIBA 02/2024
1	Phosphotransferases (Kinase)IBA 02/2024
1	Chemokine ReceptorsIBA 01/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	CTLA-4 AntigenIBA 01/2024
1	TensinsIBA 01/2024
1	ChemokinesIBA 01/2024
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2024
1	Circulating Tumor DNAIBA 01/2023
1	Everolimus FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Neurofibromin 1 (Neurofibromin)IBA 01/2022
1	atezolizumabIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	taxaneIBA 08/2021
1	cabazitaxel FDA Link 08/2021
1	Cell-Free Nucleic AcidsIBA 08/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	LuciferasesIBA 01/2021
1	AdiponectinIBA 01/2021
1	Coffee FDA Link 11/2020
1	trifluridine tipiracil drug combinationIBA 01/2020
1	25-hydroxyvitamin DIBA 12/2019
1	Genetic Markers (Genetic Marker)IBA 10/2019
1	Calcifediol (Calcidiol)FDA Link 07/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	regorafenibIBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019

Therapy/Procedure

27	Therapeutics 03/2024 - 09/2008
14	Drug Therapy (Chemotherapy) 03/2024 - 07/2017
9	Percutaneous Coronary Intervention 07/2011 - 02/2008
8	Adjuvant Chemotherapy 12/2024 - 01/2020
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2011 - 09/2008
3	Immunotherapy 01/2024 - 01/2018
2	Erythrocyte Transfusion 05/2009 - 02/2008
2	Stents 02/2008 - 02/2008
1	Drug Tapering 10/2021
1	Castration 08/2021
1	Neoadjuvant Therapy 01/2021
1	Induction Chemotherapy 01/2021
1	Combined Modality Therapy 01/2021
1	Biological Therapy 12/2019
1	Pancreaticoduodenectomy 12/2019
1	Nephrectomy 12/2018